01:39 PM EDT, 03/19/2024 (MT Newswires) -- Legend Biotech ( LEGN ) on Tuesday filed a registration with the US Securities and Exchange Commission to sell securities from time to time.

The company may offer ordinary shares, American depositary shares representing ordinary shares, debt securities and warrants and use proceeds to fund research and clinical development activities or manufacture or commercialize product candidates, among other purposes.

Shares of the company fell 2.9% in recent trading Tuesday.

Price: 62.85, Change: -1.84, Percent Change: -2.85